Partin AW - Search Results

1

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

Catalona WJ, Southwick PC, Slawin KM, Partin AW, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC, Scardino PT, Lange PH, Gasior GH, Loveland KG, Bray KR. Catalona WJ, et al. Among authors: partin aw. Urology. 2000 Aug 1;56(2):255-60. doi: 10.1016/s0090-4295(00)00637-3. Urology. 2000. PMID: 10925089 Clinical Trial.

2

Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.

Epstein JI, Pizov G, Steinberg GD, Carter HB, Pitcock R, Armas OA, Partin A, Walsh PC. Epstein JI, et al. J Urol. 1992 Jul;148(1):87-91. doi: 10.1016/s0022-5347(17)36518-7. J Urol. 1992. PMID: 1613888 Free article. Review.

3

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Partin AW, et al. J Urol. 1990 Apr;143(4):747-52. doi: 10.1016/s0022-5347(17)40079-6. J Urol. 1990. PMID: 1690309 Free article.

4

The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.

Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC. Carter HB, et al. Among authors: partin aw. J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1. doi: 10.1016/s0022-5347(17)39683-0. J Urol. 1990. PMID: 1700143

5

Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.

Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Partin AW, et al. J Urol. 1991 Feb;145(2):405-9. doi: 10.1016/s0022-5347(17)38353-2. J Urol. 1991. PMID: 1703242 Free article.

6

Pathologic findings in clinical stage A2 prostate cancer. Relation of tumor volume, grade, and location to pathologic stage.

Christensen WN, Partin AW, Walsh PC, Epstein JI. Christensen WN, et al. Among authors: partin aw. Cancer. 1990 Feb 15;65(4):1021-7. doi: 10.1002/1097-0142(19900215)65:4<1021::aid-cncr2820650430>3.0.co;2-l. Cancer. 1990. PMID: 2404561 Review.

7

The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia.

Weber JP, Oesterling JE, Peters CA, Partin AW, Chan DW, Walsh PC. Weber JP, et al. Among authors: partin aw. J Urol. 1989 Apr;141(4):987-92. doi: 10.1016/s0022-5347(17)41083-4. J Urol. 1989. PMID: 2467015

8

Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer.

Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC. Partin AW, et al. J Urol. 1989 Feb;141(2):341-5. doi: 10.1016/s0022-5347(17)40761-0. J Urol. 1989. PMID: 2913356

9

The rat as a model for the study of penile erection.

Quinlan DM, Nelson RJ, Partin AW, Mostwin JL, Walsh PC. Quinlan DM, et al. Among authors: partin aw. J Urol. 1989 Mar;141(3):656-61. doi: 10.1016/s0022-5347(17)40926-8. J Urol. 1989. PMID: 2918611

10

Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.

Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Partin AW, et al. Urol Clin North Am. 1993 Nov;20(4):713-25. Urol Clin North Am. 1993. PMID: 7505980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters